MHRA is an executive agency, sponsored by the Department of Health and Social Care. We publish the most up-to-date information for a medicine according to its licence history. You can use the A-Z list to find an active substance, or search for a medicine. We publish scientific. The UK Medicines and Healthcare products Regulatory Agency (MHRA) is an executive agency of the UK Department of Health with responsibility for authorising the marketing of medicines and medical .
MHRA-GMDP contains information relating to manufacturing and wholesale distribution authorisations, API registrations and GMP/GDP certificates. Notified E-cigarette products published for supply. 3 days ago · The reports of the two deaths of a man and a woman were made to the Medicines and Healthcare products Regulatory Agency (MHRA). The MHRA was established in 2003 through the merger of the Medicines Control Agency (MCA) and the Medical Devices Agency (MDA). The creation of a single regulator was intended to streamline .
2 days ago · Of the two deaths reported to the MHRA, one was made in connection with Mounjaro, while the other was linked to an unspecified semaglutide, the active ingredient in weight-loss jabs. The Medicines and Healthcare products Regulatory Agency has issued a recall for a single batch of Ramipril 5 mg Capsules manufactured by Crescent Pharma Limited. The precautionary measure . 1 day ago · Nottingham, UK - Upperton has submitted its application to the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the approval of its new 7,000 sq. ft sterile .
3 days ago · These developments build on the January 2026 package of MHRA guidance. Central to the update is new draft guidance on good manufacturing practice (GMP) for investigational medicinal .
- The reports of the two deaths of a man and a woman were made to the Medicines and Healthcare products Regulatory Agency (MHRA).
- Of the two deaths reported to the MHRA, one was made in connection with Mounjaro, while the other was linked to an unspecified semaglutide, the active ingredient in weight-loss jabs.
- MHRA issues recall for blood pressure medication after packaging.
Upperton Submits MHRA Licence Application for Annex 1 Sterile. This indicates that "MHRA approves deuruxolitinib (Leqselvi) to treat severe alopecia areata in adults" should be tracked with broader context and ongoing updates.
Nottingham, UK - Upperton has submitted its application to the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the approval of its new 7,000 sq. For readers, this helps frame potential impact and what to watch next.
FAQ
What happened with MHRA approves deuruxolitinib (Leqselvi) to treat severe alopecia areata in adults?
MHRA publishes draft GMP guidance for investigational medicinal.
Why is MHRA approves deuruxolitinib (Leqselvi) to treat severe alopecia areata in adults important right now?
These developments build on the January 2026 package of MHRA guidance.
What should readers monitor next?
Watch for official updates, verified data changes, and follow-up statements from primary sources.
